When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TRIL - Calithera Biosciences Poised For Long-Term Success
Trillium Therapeutics Inc.
Calithera has an important near-term catalyst that could launch the company into a significant commercialization opportunity by mid-year 2021.
The company also is running a triplet therapy trial that if successful, would be the only treatment in a $10B market.
Calithera is a high-risk, high reward speculative investment addressing high unmet and under-served needs markets, with a lower bar data threshold to meet.